Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: The fat lady sings

Journal of the American Society of Nephrology

Volumn 16, Issue 7, 2005, Pages 1880-1882

  Sedor, John R ^a,b   Schelling, Jeffrey R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rammelkamp Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; ENDOPLASMIC RETICULUM; FOLLOW UP; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MEDICAL LITERATURE; METABOLIC SYNDROME X; PRIORITY JOURNAL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; KIDNEY DISEASE; NOTE; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; HUMANS; KIDNEY DISEASES; METABOLIC SYNDROME X; RISK FACTORS;

EID: 27744567019     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005050513     Document Type: Editorial

References (27)

1. Schelling JR, Sedor JR: The metabolic syndrome as a risk factor for chronic kidney disease: More than a fat chance? J Am Soc Nephrol 15: 2773-2774, 2004
2. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689, 2001
4. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27: 2444-2449, 2004
5. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in american adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation 110: 2494-2497, 2004
6. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk of chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005
7. ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol. 129: 687-702, 1989
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
9. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342: 1887-1892, 2000
10. McAlister FA: Applying evidence to patient care: From black and white to shades of grey. Ann Intern Med 138: 938-939, 2003
11. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH: Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int 67: 1684-1691, 2005
12. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140: 167-174, 2004
13. Muntner P, He J, Chen J, Fonseca V, Whelton PK: Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: Analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 14: 686-695, 2004
14. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
15. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004
16. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002
17. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142: 323-332, 2005
18. Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH: Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med 142: 313-322, 2005
19. Lindstrom J, Tuomilehto J: The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 26: 725-731, 2003
20. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Intern Med 136: 575-581, 2002
21. Sjoholm A, Nystrom T: Endothelial inflammation in insulin resistance. Lancet 365: 610-612, 2005
22. Reilly MP, Rader DJ: The metabolic syndrome: More than the sum of its parts? Circulation 108: 1546-1551, 2003
23. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003
24. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The Mild and Moderate Kidney Disease Study. J Am Soc Nephrol 16: 1091-1098, 2005
25. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004
26. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, Hori M: Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 10:1128-1132, 2004
27. Bridgewater DJ, Ho J, Sauro V, Matsell DG: Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. Kidney Int 67: 1308-1314, 2005